Hancock Jaffe Changes Name To enVVeno, Drops Cardiac Device To Focus On Venous Disease
Executive Summary
The company will focus on developing its VenoValve system to treat chronic venous insufficiency and a second product for venous disease.
You may also be interested in...
Hancock Jaffe Sells $41.4M In Stock To Fund Venous Therapies
The new public offering will fund the US pivotal trial of the company’s VenoValve device to treat chronic deep venous insufficiency in the legs.
CMR Signs Deal With J&J To Bring Robots To Europe And South America
CMR Surgical will collaborate with Johnson & Johnson/Ethicon to expand access to its Versius robotic surgery system.
Cordis Looks To Regain Previous Innovation Edge With Drug-Eluting Balloons
Medtech Insight followed-up with Cordis CEO Shar Matin to talk about the company’s path forward as an innovative intervention company following the acquisition of MedAlliance.